Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Novel TGF-beta inhibitors disclosed by U.S. institutions

Nov. 26, 2014

U.S. investigators disclose new class II FBA inhibitors

Nov. 26, 2014

Merck KGaA patents new GCN2 inhibitors

Nov. 26, 2014

Principia Biopharma reports discovery of FGFR inhibitors

Nov. 25, 2014

Sanofi develops novel CD38 inhibitors

Nov. 25, 2014

Max-Planck-Gesellschaft and BTI divulge natural PPAR modulators

Nov. 25, 2014

Galapagos patents novel CFTR activators

Nov. 24, 2014

Kissei Pharmaceutical discloses new TRPM8 antagonists

Nov. 24, 2014

New GABA(A) receptor agonists disclosed by Sichuan Haisco

Nov. 24, 2014

Nimbus Apollo reports new ACC2 inhibitors

Nov. 24, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 27, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...